Biosante Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Biosante Pharmaceuticals Inc
CIK #0001023024
EDGAR Form CIK 2011 - 2026
10-K [0001023024]
10-Q [0001023024]
3 [0001023024]
4 [0001023024]
5 [0001023024]
8-K [0001023024]
SC 13D [0001023024]
SC 13G [0001023024]
Form 13D/13G Filer Form 13D/13G Subject Filed
Integrated Core Strategies US LLC ANI Pharmaceuticals Inc [2025-06-04]
Millennium Management LLC ANI Pharmaceuticals Inc [2025-01-21]
Vanguard Group Inc ANI Pharmaceuticals Inc [2024-02-13]
Rubric Capital Management LP ANI Pharmaceuticals Inc [2024-02-12]
Esjay LLC ANI Pharmaceuticals Inc [2022-03-02]
Allianz Global Investors US Holdings LLC ANI Pharmaceuticals Inc [2018-02-15]
Allianz Global Investors US Holdings LLC ANI Pharmaceuticals Inc [2017-02-14]
Consonance Capital Management LP ANI Pharmaceuticals Inc [2015-02-17]
BlackRock Inc ANI Pharmaceuticals Inc [2015-02-03]
Marshbanks Tracy ANI Pharmaceuticals Inc [2015-02-03]
View All
Form 3/4/5 Subject 2011 - 2026
ANI Pharmaceuticals Inc
Carey Stephen P
Cook Meredith
Tannenbaum Renee P
Pera Antonio R
Leonard Matthew J
Thoma Jeanne
Haughey Thomas
Gutwerg Ori
Lalwani Nikhil
Walsh Patrick D
Rowland Thomas Andrew
Mutz Christopher
Davis Krista
Gassert Chad
Shanmugam Muthusamy
Marken James G
Brown Robert E JR
Meridian Venture Partners II Co
Meridian Venture Partners II GP LP
Meridian Venture Partners II LP
Nash David
Schrepfer Robert W
Przybyl Arthur
Penn Thomas A
Marshbanks Tracy
Holubow Fred
Raynor Daniel
Lankau Peter A
Arnold Charlotte C
Mangano Ross J
Jamnick Robert J
Rosenow Edward C III
Sherwin Stephen A
Potts John T Jr
Sullivan Louis W
Snabes Michael C
Donenberg Philip B
Simes Stephen M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-13 Sell 500 $72.62 36,310
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-13 Sell 3,162 $71.64 226,526
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-11 Sell 4,772 $74.91 357,471
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-09 Sell 3,602 $74.18 267,196
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-09 Sell 5,087 $74.13 377,099
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-07 Tax withheld 17,060 $74.04 1,263,122
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-07 Tax withheld 3,314 $74.04 245,369
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-07 Tax withheld 5,150 $74.04 381,306
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-07 Tax withheld 3,314 $74.04 245,369
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-06 Sell 2,121 $74.22 157,421
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-06 Sell 1,485 $75.00 111,375
ANI Pharmaceuticals Inc ANIP
Stock Option (right to buy) · derivative
2026-03-05 Option exercise 3,312 $49.51 163,977
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-05 Sell 4,000 $75.56 302,240
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-05 Option exercise 3,312 $49.51 163,977
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-05 Sell 3,312 $75.42 249,791
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-03 Sell 6,000 $74.23 445,380
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-03 Sell 2,060 $76.50 157,590
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-03-02 Sell 417 $74.00 30,858
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-02-28 Tax withheld 2,221 $73.90 164,132
ANI Pharmaceuticals Inc ANIP
Common Stock
2026-02-28 Tax withheld 1,555 $73.90 114,915
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com